Tramazac Co 37,5 mg & 325 mg FC tablets
PDF Leaflet Revision Date: 01 March 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately severe pain in adults.
Dosage (summary)
1-2 tablets every 4-6 hours as needed, max 8 tablets/day.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- MAOIs
- CNS depressants
- Serotonergic medicines
Contraindications
- Hypersensitivity to tramadol or paracetamol
- Severe hepatic impairment
- Acute intoxication with CNS depressants
- Children under 12 years
Common side effects
- Nausea
- Dizziness
- Somnolence
Counselling Points
- Do not exceed recommended dose.
- Monitor for signs of misuse or dependence.
- Avoid alcohol and CNS depressants.
Serious warnings
- Risk of seizures
- Risk of respiratory depression
- Potential for addiction
Important Disclaimer
The Tramazac Co 37,5 mg & 325 mg FC tablets professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
